SGRY stock news
This page provides real-time market news, earnings updates, and company announcements related to Surgery Partners, Inc. (SGRY).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-27 09:33 EST
Da Vinci 5 Sparks Optimism Around Intuitive Surgical, Inc. (ISRG)
Finviz2026-02-23 20:39:34
SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance
Finviz2026-02-23 21:12:11
Ocular Therapeutix to Participate in March Investor Conferences
Finviz2026-02-24 12:03:59
Ocular Therapeutix to Participate in March Investor Conferences
Finviz2026-02-24 12:03:59
BioRestorative Expands Global Protection for ThermoStem, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs
Finviz2026-02-24 13:33:08
Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY Endovascular Robotic System
Finviz2026-02-24 13:33:08
Regeneron, Sanofi Blockbuster Dupixent Scores FDA Nod For Rare Sinus Condition
Finviz2026-02-24 18:48:46
Dimon Warns: Current Market Resembles the Eve of the Financial Crisis
新浪财经2026-02-25 08:40:40
Opus Genetics: Phentolamine sNDA Approval and the Genuine Disparity in Expectations
101 finance2026-02-25 12:18:41
Apyx Medical Corporation to Release Fourth Quarter of Fiscal Year 2025 Financial Results on March 10, 2026
Finviz2026-02-25 14:03:11
Top Robotics Shares to Consider Investing in Now for Strong Profits
101 finance2026-02-25 14:27:54
What's Going On With Allurion Stock On Wednesday?
Finviz2026-02-25 15:42:44
Longeveron Results of Phase 2b Clinical Trial Demonstrating Stem Cell Therapy Improved Condition of Patients with Age-Related Frailty Published in Cell Stem Cell
Finviz2026-02-25 16:09:44
Stryker Introduces Synchfix EVT for Versatile Syndesmotic Stabilization
101 finance2026-02-25 18:04:05
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA (desmopressin acetate) Oral Solution
Finviz2026-02-25 18:51:43
Carlsmed Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-02-25 21:03:42
LENSAR Provides Update on Pending Acquisition by Alcon
Finviz2026-02-25 22:03:05
Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026
Finviz2026-02-26 12:03:47
Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results
Finviz2026-02-26 13:03:43
TEM vs. ILMN: Which MedTech Stock Offers Greater Upside?
Finviz2026-02-26 16:51:57
Intuitive Surgical vs. Abbott: Which Medical Technology Stock Offers Greater Potential Today?
101 finance2026-02-26 17:30:52
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 21:09:43
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results
Finviz2026-02-27 12:12:40
ZUSDURI Achieves Durable Complete Responses Across EORTC Risk Groups in Patients with Recurrent LG-IR-NMIBC
Finviz2026-02-27 13:33:07
BioRestorative Expands Global Protection for ThermoStem, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs
Finviz2026-02-24 13:33:08
Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY Endovascular Robotic System
Finviz2026-02-24 13:33:08
Regeneron, Sanofi Blockbuster Dupixent Scores FDA Nod For Rare Sinus Condition
Finviz2026-02-24 18:48:46
Dimon Warns: Current Market Resembles the Eve of the Financial Crisis
新浪财经2026-02-25 08:40:40
Opus Genetics: Phentolamine sNDA Approval and the Genuine Disparity in Expectations
101 finance2026-02-25 12:18:41
Apyx Medical Corporation to Release Fourth Quarter of Fiscal Year 2025 Financial Results on March 10, 2026
Finviz2026-02-25 14:03:11
Top Robotics Shares to Consider Investing in Now for Strong Profits
101 finance2026-02-25 14:27:54
What's Going On With Allurion Stock On Wednesday?
Finviz2026-02-25 15:42:44
Longeveron Results of Phase 2b Clinical Trial Demonstrating Stem Cell Therapy Improved Condition of Patients with Age-Related Frailty Published in Cell Stem Cell
Finviz2026-02-25 16:09:44
Stryker Introduces Synchfix EVT for Versatile Syndesmotic Stabilization
101 finance2026-02-25 18:04:05
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA (desmopressin acetate) Oral Solution
Finviz2026-02-25 18:51:43
Carlsmed Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-02-25 21:03:42
LENSAR Provides Update on Pending Acquisition by Alcon
Finviz2026-02-25 22:03:05
Upstream Bio to Present Additional Analyses from Phase 2 VIBRANT Trial in Chronic Rhinosinusitis with Nasal Polyps in Late-Breaking Session at AAAAI Annual Meeting 2026
Finviz2026-02-26 12:03:47
Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results
Finviz2026-02-26 13:03:43
TEM vs. ILMN: Which MedTech Stock Offers Greater Upside?
Finviz2026-02-26 16:51:57
Intuitive Surgical vs. Abbott: Which Medical Technology Stock Offers Greater Potential Today?
101 finance2026-02-26 17:30:52
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-26 21:09:43
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results
Finviz2026-02-27 12:12:40
ZUSDURI Achieves Durable Complete Responses Across EORTC Risk Groups in Patients with Recurrent LG-IR-NMIBC
Finviz2026-02-27 13:33:07
SGRY stock chart
SGRY stock detailsSGRY stock price change
On the last trading day, SGRY stock closed at 15.21 USD, with a price change of -1.81% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more